Minimal change nephrotic syndrome showing complete remission after resection of a neurofibroma in a type I neurofibromatosis patient

DOI QR Code

Hyun, Ji In (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
Min, Ji Won (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
Lee, Hye Min (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
Kim, Yong Kyun (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
Choi, Eu Jin (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
Song, Ho Cheol (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)

Khan GA, Melman A, Bank N. Renal involvement in neurocutaneous syndromes. J Am Soc Nephrol 1995;5:1411-1417.
Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 2003;18 Suppl 6:vi52-vi58.
Xu GF, O'Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599-608. https://doi.org/10.1016/0092-8674(90)90024-9
Godel M, Hartleben B, Herbach N, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 2011;121:2197-2209. https://doi.org/10.1172/JCI44774
Hsueh YP, Roberts AM, Volta M, Sheng M, Roberts RG. Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci 2001;21:3764-3770. https://doi.org/10.1523/JNEUROSCI.21-11-03764.2001

A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I vol.7, pp.1, 2017, https://doi.org/10.1007/s13730-018-0309-2